Literature DB >> 19052134

Sorafenib in advanced hepatocellular carcinoma.

Giancarlo Spinzi, Silvia Paggi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052134     DOI: 10.1056/NEJMc081780

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  Neutrophil-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib.

Authors:  Kai Wei; Meng Wang; Wei Zhang; Han Mu; Tian-Qiang Song
Journal:  Med Oncol       Date:  2014-05-04       Impact factor: 3.064

2.  Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cells.

Authors:  Rong Bian; Jinkai Zhao; Zhongcai Yao; Yajun Cai; Chenting Shou; Dayong Lou; Liqin Zhou; Yuanyuan Qian
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 3.  Methodological assessment of HCC literature.

Authors:  G Daniele; N Costa; V Lorusso; J Costa-Maia; I Pache; M Pirisi
Journal:  Ann Oncol       Date:  2013-04       Impact factor: 32.976

Review 4.  Sorafenib: a review of its use in advanced hepatocellular carcinoma.

Authors:  Gillian M Keating; Armando Santoro
Journal:  Drugs       Date:  2009       Impact factor: 9.546

5.  Expression of Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) Exacerbates Hepatocellular Carcinoma Through Suppressing miR-195.

Authors:  Hui Zhang; Dong Zhou; Mingang Ying; Minyong Chen; Peng Chen; Zhaoshuo Chen; Fan Zhang
Journal:  Med Sci Monit       Date:  2016-12-09

6.  Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma.

Authors:  Jianhua Liu; Yahui Liu; Lingyu Meng; Kai Liu; Bai Ji
Journal:  Oncol Rep       Date:  2017-06-14       Impact factor: 3.906

Review 7.  Immunotherapy in Gastrointestinal Cancers.

Authors:  Letizia Procaccio; Marta Schirripa; Matteo Fassan; Loredana Vecchione; Francesca Bergamo; Alessandra Anna Prete; Rossana Intini; Chiara Manai; Vincenzo Dadduzio; Alice Boscolo; Vittorina Zagonel; Sara Lonardi
Journal:  Biomed Res Int       Date:  2017-07-03       Impact factor: 3.411

8.  Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.

Authors:  Minhua Rong; Gang Chen; Yiwu Dang
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430

9.  Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.

Authors:  Suning Huang; Rongquan He; Minhua Rong; Yiwu Dang; Gang Chen
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

Review 10.  Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers.

Authors:  Cornelia Braicu; Claudia Burz; Ioana Berindan-Neagoe; Ovidiu Balacescu; Florin Graur; Victor Cristea; Alexandru Irimie
Journal:  Gastroenterology Res       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.